Daily analysis of Indian market events grounded in real corporate filings. Every claim is backed by what companies actually said in their annual reports and quarterly results.
The Sensex fell 374 points as crude oil spiked on West Asia tensions. We dug into filings to find which companies are most exposed — and which quietly benefit.
Sun Pharma agreed to Most Favoured Nation pricing in the US to delay tariffs. We dig into filings to find which Indian pharma companies face margin pressure — and which CDMOs stand to gain.
As Commerce Ministry meets exporters ahead of Goyal-Greer talks, company filings reveal which stocks have been hurt by tariffs and stand to gain from a deal.
The US is considering slashing China tariffs to 7.5% ahead of the September 24 Xi-Trump summit. India locked in an 18% rate in its own trade deal. We dug through filings to find the companies that explicitly cite their tariff edge over China — and now face the biggest risk.
Trump's drug import order sets a 25% tariff ceiling on pharmaceuticals. We dig into filings to find which Indian pharma exporters — Lupin, Sun Pharma, Cipla, Dr. Reddy's — are most exposed.
The US announced tighter H-1B rules and paused immigrant visas, tanking IT stocks. But filings reveal a sharp divide: large-caps have quietly insulated themselves while smaller companies face real margin pain.
The India-US interim trade agreement could accelerate electronics manufacturing exports. We dug through filings to find the EMS companies with real capacity, growing order books, and US exposure.
India's stricter E20 ethanol blending mandates for oil marketing companies create a guaranteed demand runway. We dig into the filings of 7 companies that have been quietly building distillery capacity — from TruAlt's 2,000 KLPD platform to BCL Industries' 4.8x revenue surge.
Government restricts ethanol diversion and eases sugar imports as prices surge. We dig into filings to find which sugar mills are best positioned for the policy pivot.
India Inc Q1 FY27 earnings hit a 3-year high, but oil and mining companies inflate the aggregate. The real growth story is in consumer durables — Havells, Voltas, Asian Paints — powered by domestic demand, not commodity windfalls.
While the Nifty suffers its worst losing streak in months, ONGC and Oil India are posting record quarters. Here's who wins and who loses as crude crosses $91.
The SHANTI Act draft rules let private companies build nuclear reactors in India for the first time. We dug into filings to find who has the contracts, the equipment, and the head start.
India's trade deals with the UK, EU, and US are removing 9-12% tariffs on textiles. We dug into the filings of six listed companies with the capacity, order books, and margins to capture this structural shift.
The White House labels India a Tier-1 hub for Chinese tariff evasion. Companies with genuine domestic manufacturing stand to gain; re-exporters face new penalties.
RBI draft rules would standardize loan pricing around external benchmarks and cap spreads. We dig into filings to find which lenders win and which face margin pressure.